METHYLPREDNISOLONE ACETATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Methylprednisolone Acetate, and what generic alternatives are available?
Methylprednisolone Acetate is a drug marketed by Amneal, Endo Operations, Epic Pharma Llc, Eugia Pharma, Hong Kong, Sagent Pharms Inc, Sandoz, Teva Pharms Usa, Watson Labs, and Wilshire Pharms Inc. and is included in seventeen NDAs.
The generic ingredient in METHYLPREDNISOLONE ACETATE is methylprednisolone acetate. There are forty drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methylprednisolone Acetate
A generic version of METHYLPREDNISOLONE ACETATE was approved as methylprednisolone acetate by HONG KONG on February 23rd, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METHYLPREDNISOLONE ACETATE?
- What are the global sales for METHYLPREDNISOLONE ACETATE?
- What is Average Wholesale Price for METHYLPREDNISOLONE ACETATE?
Summary for METHYLPREDNISOLONE ACETATE
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 17 |
| Finished Product Suppliers / Packagers: | 10 |
| Raw Ingredient (Bulk) Api Vendors: | 46 |
| Clinical Trials: | 38 |
| Patent Applications: | 4,147 |
| Drug Prices: | Drug price information for METHYLPREDNISOLONE ACETATE |
| DailyMed Link: | METHYLPREDNISOLONE ACETATE at DailyMed |
See drug prices for METHYLPREDNISOLONE ACETATE
Recent Clinical Trials for METHYLPREDNISOLONE ACETATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Menoufia University | N/A |
| Centre hospitalier de l'Université de Montréal (CHUM) | Phase 4 |
| Yale University | Phase 2 |
Pharmacology for METHYLPREDNISOLONE ACETATE
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for METHYLPREDNISOLONE ACETATE
US Patents and Regulatory Information for METHYLPREDNISOLONE ACETATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wilshire Pharms Inc | METHYLPREDNISOLONE ACETATE | methylprednisolone acetate | INJECTABLE;INJECTION | 214870-002 | May 10, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Wilshire Pharms Inc | METHYLPREDNISOLONE ACETATE | methylprednisolone acetate | INJECTABLE;INJECTION | 214870-001 | Jan 3, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Amneal | METHYLPREDNISOLONE ACETATE | methylprednisolone acetate | INJECTABLE;INJECTION | 210043-001 | May 20, 2019 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sandoz | METHYLPREDNISOLONE ACETATE | methylprednisolone acetate | INJECTABLE;INJECTION | 040719-002 | Jan 29, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs | METHYLPREDNISOLONE ACETATE | methylprednisolone acetate | INJECTABLE;INJECTION | 085374-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Epic Pharma Llc | METHYLPREDNISOLONE ACETATE | methylprednisolone acetate | INJECTABLE;INJECTION | 086903-001 | Oct 20, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
